Seeing Is Believing
ABEO is currently covered by 2 analysts with an average potential upside of $165.23 (125.04%) backed by displayed 40 price targets and 44 ratings.
Analysts average stock forecasts to be materialized ratio is 41.67% with an average time for these price targets to be met of 117.36 days.
Highest price target for ABEO is 5, Lowest price target is 4, average price target is 4.5.
Most recent stock forecast was given by KRISTEN KLUSKA from CANTOR FITZGERALD on 24-Aug-2023. First documented stock forecast 16-Dec-2015.
Currently, out of the existing stock ratings of ABEO - 4 which are a Buy (80%), 1 which are a Hold (20%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
38
$33.79 (802.61%)
38
1 months 6 days ago
3/6 (50%)
$19.76 (354.50%)
25
Hold
6
$1.79 (42.52%)
10 months 16 days ago
0/2 (0%)
$39.3 (74.68%)
Buy
75
$70.79 (1681.47%)
50
2 years 10 months 19 days ago
2/3 (66.67%)
$45.92 (117.11%)
101
Buy
175
$170.79 (4056.77%)
575
3 years 4 months 22 days ago
0/3 (0%)
$210.42 (128.85%)
Buy
50
$45.79 (1087.65%)
850
4 years 1 months 18 days ago
3/4 (75%)
$297.56 (174.27%)
376
What is ABEO (Abeona Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on ABEO (Abeona Therapeutics) with a proven track record?
Which analyst has the most public recommendations on ABEO (Abeona Therapeutics)?
Which analyst is the currently most bullish on ABEO (Abeona Therapeutics)?
Which analyst is the currently most reserved on ABEO (Abeona Therapeutics)?